Almoosa Health Company (TADAWUL:4018)
Saudi Arabia · Delayed Price · Currency is SAR 117.10
-1.30 (-1.10%)
Jun 11, 2026, 3:13 PM AST
Almoosa Health Company Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Almoosa Health Company stock has a consensus rating of "Hold" and an average price target of SAR 183.47. The average 1-year stock price forecast is 56.68% higher than the current stock price, while the lowest is SAR 168.90 (+44.24%) and the highest is SAR 191.50 (+63.54%).
Price Target: SAR 183.47 (+56.68%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Almoosa Health Company stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
1.70B
from 1.42B
Increased by 20.10%
Revenue Next Year
2.08B
from 1.70B
Increased by 22.53%
EPS This Year
6.58
from 5.52
Increased by 19.10%
EPS Next Year
6.98
from 6.58
Increased by 6.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.7B | ||
| Avg | 1.7B | ||
| Low | 1.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.6% | ||
| Avg | 20.1% | ||
| Low | 18.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 6.58 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 19.1% | ||
| Low | - |